Cubist Systematic Strategies, LLC Trans Medics Group, Inc. Call Options Transaction History

Cubist Systematic Strategies, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$135.68 - $176.11 $909,056 - $1.18 Million	-6,700 Reduced 21.68%	24,200 $3.8 Million
Q2 2024 Aug 14, 2024	BUY	$72.62 - $150.62 $944,060 - $1.96 Million	13,000 Added 72.63%	30,900 $4.65 Million
Q1 2024 May 15, 2024	BUY	$70.86 - $89.93 $751,116 - $953,258	10,600 Added 145.21%	17,900 $1.32 Million
Q4 2023 Feb 14, 2024	BUY	$36.74 - $81.08 $121,242 - $267,564	3,300 Added 82.5%	7,300 $576,000
Q3 2023 Nov 14, 2023	BUY	$53.47 - $96.07 $58,817 - $105,676	1,100 Added 37.93%	4,000 $219,000
Q1 2023 May 15, 2023	BUY	$53.63 - $82.33 $155,527 - $238,757	2,900 New	2,900 $219,000

395

31.9M

466K

286K

Ticker TMDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 31,831,400
Market Cap $2.58B
Description
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.